Kynam Capital Management, LP Amicus Therapeutics, Inc. Transaction History

Kynam Capital Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$9.82 - $12.75 $2.19 Million - $2.85 Million	-223,151 Reduced 24.79%	676,849 $7.07 Million
Q2 2022 Aug 15, 2022	BUY	$6.23 - $11.12 $2.03 Million - $3.63 Million	326,484 Added 56.93%	900,000 $9.67 Million
Q1 2022 May 13, 2022	SELL	$7.89 - $12.48 $1,443 - $2,283	-183 Reduced 0.03%	573,516 $5.43 Million
Q4 2021 Feb 14, 2022	BUY	$9.82 - $12.44 $5.63 Million - $7.14 Million	573,699 New	573,699 $6.63 Million

311

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.53B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Kynam Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Kynam Capital Management, LP with notifications on news.